(Q43728206)

26 November 2017

title

Myc lacks E2F1's ability to suppress skin carcinogenesis (English)

1 reference

26 November 2017

1 reference

Rounbehler RJ

1

1 reference

26 November 2017

Schneider-Broussard R

series ordinal

2

1 reference

26 November 2017

Conti CJ

series ordinal

3

1 reference

26 November 2017

Johnson DG

series ordinal

4

1 reference

26 November 2017

language of work or name

English

0 references

publication date

1 August 2001

1 reference

26 November 2017

1 reference

26 November 2017

volume

20

1 reference

26 November 2017

issue

38

1 reference

26 November 2017

page(s)

5341-5349

1 reference

The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204691

The ornithine decarboxylase gene is a transcriptional target of c-Myc

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204691

Direct induction of cyclin D2 by Myc contributes to cell cycle progression and sequestration of p27.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204691

Expression analysis with oligonucleotide microarrays reveals that MYC regulates genes involved in growth, cell cycle, signaling, and adhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204691

Cellular targets for activation by the E2F1 transcription factor include DNA synthesis- and G1/S-regulatory genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204691

Overexpression of E2F-1 in glioma triggers apoptosis and suppresses tumor growth in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204691

Mediation of c-Myc-induced apoptosis by p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204691

E1A-dependent trans-activation of the human MYC promoter is mediated by the E2F factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204691

The paradox of E2F1: oncogene and tumor suppressor gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204691

Oncogenic capacity of the E2F1 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204691

Expression of transcription factor E2F1 induces quiescent cells to enter S phase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204691

Microinjected c-myc as a competence factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204691

Myc and Ras collaborate in inducing accumulation of active cyclin E/Cdk2 and E2F.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204691

Increased E2F1 activity induces skin tumors in mice heterozygous and nullizygous for p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204691

E2F1 has both oncogenic and tumor-suppressive properties in a transgenic model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204691

Transgenic mice bearing the human c-myc gene activated by an immunoglobulin enhancer: a pre-B-cell lymphoma model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204691

Rapid analysis of gene expression (RAGE) facilitates universal expression profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204691

Regulation of BRCA1 expression by the Rb-E2F pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204691

E2F4 and E2F1 have similar proliferative properties but different apoptotic and oncogenic properties in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204691

p53 and E2F-1 cooperate to mediate apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204691

Multiple members of the E2F transcription factor family are the products of oncogenes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204691

Dual functions of E2F-1 in a transgenic mouse model of liver carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204691

7 January 2021

Myc/p53 interactions in transgenic mouse mammary development, tumorigenesis and chromosomal instability

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204691

7 January 2021

Oncogene amplification in squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204691

7 January 2021

Reversible activation of c-Myc in skin: induction of a complex neoplastic phenotype by a single oncogenic lesion

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204691

7 January 2021

Deregulated expression of E2F1 induces hyperplasia and cooperates with ras in skin tumor development

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204691

7 January 2021

Sequences 5' of the bovine keratin 5 gene direct tissue- and cell-type-specific expression of a lacZ gene in the adult and during development

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204691

7 January 2021

Spontaneous mammary adenocarcinomas in transgenic mice that carry and express MTV/myc fusion genes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204691

7 January 2021

Targeted expression of c-Myc in the epidermis alters normal proliferation, differentiation and UV-B induced apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204691

7 January 2021

Tumor induction and tissue atrophy in mice lacking E2F-1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204691

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1204691

1 reference

Dimensions Publication ID

26 November 2017

1052548298

0 references

1 reference